Search results
16 gru 2021 · Background: The major reasons to treat sarcoidosis are to lower the morbidity and mortality risk or to improve quality of life (QoL). The indication for treatment varies depending on which manifestation is the cause of symptoms: lungs, heart, brain, skin or other manifestations.
- Treatment of Sarcoidosis: A Multidisciplinary Approach - PMC
Treatment is directed at alleviating organ dysfunction,...
- New sarcoidosis guidelines: Are we near to perfection? - PMC
In 2021, the multi-disciplinary ERS task force developed...
- Treatment of Sarcoidosis: A Multidisciplinary Approach - PMC
A comprehensive guide for physicians to manage sarcoidosis, a chronic inflammatory disease that affects multiple organs. Includes goals of treatment, pharmacologic and non-pharmacologic options, and quality-of-life issues.
29 lis 2022 · Sarcoidosis is a heterogeneous disease with variable organ involvement, disease course, and response to treatment. We offer an angle on when and how to treat, and provide an overall roadmap for managing sarcoidosis.
Treatment is directed at alleviating organ dysfunction, preventing irreversible scarring, and improving quality of life. Herein, we review the indications for treatment, pharmacotherapy, treatment duration, side effects, adjunct non-pharmacologic therapies, and outcomes for patients.
16 gru 2021 · ERS clinical practice guidelines on treatment of sarcoidosis. Baughman RP 1 , Valeyre D 2 , Korsten P 3 , Mathioudakis AG 4 , Wuyts WA 5 , Wells A 6 , Rottoli P 7 , Nunes H 8 , Lower EE 9 , Judson MA 10 , Israel-Biet D 11 , Grutters JC 12 , Drent M 12 , Culver DA 13 , Bonella F 14 , Antoniou K 15 , Martone F 16 , Quadder B 17 , Spitzer G 18 ,
8 wrz 2021 · Treatment guidelines for sarcoidosis are evolving, and health care providers are advised to consider a personalized approach based on individual variations in disease manifestations (Tables...
20 kwi 2022 · In 2021, the multi-disciplinary ERS task force developed eight clinical questions on PICO (Patients, Intervention, Comparison, Outcomes) format targeting treatment of sarcoidosis and made recommendations based on GRADE (Grading of Recommendations Assessment, Development and Evaluation) methodology.
